Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The metric has seen a significant gain of 14.07% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -10.01%. Over the past 30 days, the price of AZN has fallen by 3.82%. And in the last five days, it has fallen by -3.25%.
Astrazeneca plc ADR experienced a rather steady stock market performance. The highest value in the past year was recorded at $87.68 on 08/30/24 and the lowest value was $62.75 on 11/18/24.
52-week price history of AZN Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Astrazeneca plc ADR’s current trading price is -14.75% away from its 52-week high, while its distance from the 52-week low is 19.11%. The stock’s price range during this period has varied between$62.75 and $87.68. The Astrazeneca plc ADR’s shares, which operate in the Healthcare, saw a trading volume of around 2.0 million for the day, a figure considerably lower than their average daily volume of 5.61 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Astrazeneca plc ADR (AZN) has experienced a quarterly rise of 10.68% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 231.79B and boasts a workforce of 94300 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 69.92, with a change in price of -3.61. Similarly, Astrazeneca plc ADR recorded 5,830,795 in trading volume during the last 100 days, posting a change of -4.63%.
AZN’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for AZN stands at 0.74. Similarly, the long-term debt-to-equity ratio is also 0.68.
AZN Stock Stochastic Average
As of today, Astrazeneca plc ADR’s raw stochastic average for the last 50 days stands at 72.62%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 39.10%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 62.96% and 77.14%, respectively.
